Anthony J. Fitzpatrick

Thomas J. Kowalski

Jonathan Lourie

Vicki G. Norton

Sandra G. Stoneman

PHILADELPHIA, October 15, 2020—Duane Morris LLP attorneys Anthony J. Fitzpatrick, Thomas J. Kowalski, Jonathan Lourie, Vicki G. Norton and Sandra G. Stoneman have been selected as Life Sciences Stars by Legal Media Group (LMG). Based on client and peer interviews and surveys, Life Sciences Stars are recognized as those who have been consistently recommended as reputable and effective attorneys servicing the industry.

Anthony J. Fitzpatrick is a partner in the firm’s Boston office and co-chair of Duane Morris’ Patent Litigation division. His practice focuses on patent, trade secret and other technology-related litigation. Fitzpatrick has extensive experience as lead counsel at trials in federal and state courts and in arbitration. He has also argued before the Court of Appeals for the Federal Circuit and before the Patent Trial and Appeal Board of the USPTO. He has litigated matters involving diverse technologies and has gained particular experience in the life sciences, including pharmaceuticals, biologics, medical devices and diagnostics. Fitzpatrick frequently represents clients in disputes concerning the inventorship, ownership and licensing of patents. He has extensive experience in negotiating and drafting agreements to resolve complex intellectual property disputes, including agreements to resolve litigation under the Hatch-Waxman Act.

Thomas J. Kowalski is a registered U.S. patent attorney with more than 30 years’ experience, a partner in the firm’s New York office and a member of the firm’s Intellectual Property and Life Sciences groups. His practice includes strategic biotech, chemical and medical apparatus patent preparation, prosecution, licensing, counseling, and litigation and other contentious matters, including extensive experience in matters involving plants, veterinary science, personal and personalized medicine, genetics and genetic engineering (e.g., CRISPR, TALES/TALENS, zinc fingers, siRNA, RNAi), biological inventions arising from big data/data mining/AI (including from data from massively parallel sequencing, transcriptome analyses, single cell genomics, cell signatures and the various “Seq” tools, e.g., “DropSeq,” “RNASeq” and “PerturbSeq”), virology, immunology, antibodies, vaccinology, T-cells, T-cell receptors, biologics, pharmaceuticals, medicinal chemistry, crystallography and small molecules, amongst other fields of biotechnology and chemistry. Kowalski also represents his clients in procuring and enforcing trademark rights. He obtains trademark protection domestically and worldwide, and he enforces trademark rights in the United States. Kowalski has also defended clients accused of trademark infringement, and has negotiated licenses and other agreements to avoid litigation.

Jonathan Lourie, a partner in the firm’s Boston office, represents life science related companies, universities, investors and individuals around the world in joint ventures, collaborations, licensing, mergers and acquisitions, venture capital, international law and securities law. He serves as a team lead for the Duane Morris Life Sciences and Medical Technologies Industry Group. Lourie’s experience includes representing companies in vaccines, biologics, research instruments and drug discovery, drug delivery technologies, therapeutics, diagnostics, blood products, cardiology, antimicrobials, genomics, manufacturing and oncology. Lourie also mentors companies at incubators, judges investor competitions and has written numerous articles and is a frequent speaker on the intersection of life science and the law.

Vicki G. Norton, a partner in the firm’s San Diego office, serves as a team lead for the Duane Morris Life Sciences and Medical Technologies Industry Group. In over two decades of life science patent counseling and litigation, she has devised strategies for clients to successfully counter patent claims and demands totaling more than $2 billion; has performed IP diligence for transactions and at-the-market offerings worth more than $2.5 billion; and has formulated worldwide patent strategies for clients entering public markets with valuations of more than $6 billion. Norton also audits technology portfolios and identifies patent coverage issues for her clients’ transactions, venture financings and patent enforcement opportunities. She has handled patent matters in a variety of life science fields, including precision medicine and diagnostics, biologic drugs, pharmaceuticals, immuno-oncology, stem cell technology, transgenic plants and cells, methods to screen and make gas-absorbing materials, molecular biology, nanotechnology, combinatorial chemistry, probe amplification assays, nutraceuticals, microbiology and devices for physical therapy.

Sandra G. Stoneman, a partner in the firm’s Philadelphia office, concentrates her practice in the areas of mergers and acquisitions, strategic transactions and venture xapital] financings, principally in the life sciences, medical technologies and high-tech sectors. She also counsels high-growth companies in domestic and international collaborations, licensing and partnering transactions, research agreements and other important commercial and operational arrangements. Additionally, Stoneman advises management teams and boards of directors on corporate governance and stakeholder matters. She serves as a team lead for the Duane Morris Life Sciences and Medical Technologies Industry Group and is co-chair of the Emerging Companies Group.

About Legal Media Group

Legal Media Group is the legal publishing arm of Euromoney Institutional Investor, one of the world’s leading financial publishers. Legal Media Group publishes market-leading information online and in print for in-house counsel, external practitioners and industry leaders in a number of core practice areas, including international tax, international financial law and intellectual property. LMG Life Sciences Star designations are based on case evidence, peer feedback and client feedback.

About Duane Morris

Duane Morris LLP provides innovative solutions to today’s multifaceted legal and business challenges through the collegial and collaborative culture of its more than 800 attorneys in offices across the United States and internationally. The firm represents a broad range of clients, spanning all major practices and industries.